Yinghua Hu

Yinghua Hu

Auto-generated profile, based on publicly available information

Yinghua Hu

College of Acupuncture and Tuina, Changchun University of Chinese Medicine, Changchun, Jilin, China

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2021 in Medicine
Verified
Journal Article
Open access
JWJiuru Wu
Jiuru Wu
YSYan Shi
Yan Shi
XWXichen Wang
Xichen Wang
XDXiukun Dong
Xiukun Dong
XLXinyu Liu
Xinyu Liu
YHYinghua Hu
Yinghua Hu
Background: Senile insomnia seriously affects the quality of life of the elderly. With the increase of the proportion of insomnia in the elderly, compared with the elderly with normal sleep quality, the elderly with long-term insomnia are more likely to have dizziness, fatigue, and decreased immunity. Acupuncture has shown good effects in the treatment of insomnia. At present, there is a lack of systematic review on acupuncture in the treatment of senile insomnia. We conduct this study to evaluate the efficacy and safety of acupuncture in the treatment of senile insomnia. Methods: We will search Chinese and English databases: China National Knowledge Infrastructure, Chinese Scientific and Journal Database, Wan Fang database (Wanfang), Chinese Biomedical Literature Database, PubMed, EMBASE, Cochrane library to identify articles of randomized clinical trials of acupuncture for senile insomnia. All above electronic databases will be searched from inception to September 1, 2021. RevMan 5.3 software will be used to conduct this systematic review. Results: The study will prove the efficacy and safety of acupuncture for senile insomnia. Conclusion: We plan to submit this systematic review to a peer-reviewed journal. INPLASY registration number: INPLASY202160106.

31 October 2025 in Medicine
Verified
Journal Article
Open access
XLXinyu Liu
Xinyu Liu
WZWenfeng Zhang
Wenfeng Zhang
YZYifan Zhao
Yifan Zhao
CLCheng Li
Cheng Li
YWYonggang Wang
Yonggang Wang
YHYinghua Hu
Yinghua Hu
In traditional Chinese medicine, acupuncture is considered free of harmful side effects when properly performed. Pharmacokinetics provides a valuable approach to explore how acupuncture influences drug disposition. Stimulation at specific acupoints, such as Zusanli (ST36), may modulate drug absorption and action. While most studies highlight beneficial outcomes, potential risks also deserve consideration. A systematic review was conducted to evaluate how acupuncture or electroacupuncture at ST36 affects the pharmacokinetics of various drugs. Data on changes in absorption, distribution, metabolism, and excretion, along with pharmacokinetic parameters (e.g., average plasma concentration-time curve [AUC], C max , T max ), were extracted and analyzed. Acupuncture at ST36 significantly influenced the pharmacokinetics of several compounds. For instance, it enhanced the absorption and plasma levels of Schisandra chinensis lignans and acetaminophen (APAP), increasing AUC and C max while shortening T max . Tissue distribution also shifted, with elevated concentrations observed in certain organs such as the lungs. While aspirin metabolism remained unaffected, ST36 stimulation delayed APAP clearance at higher doses, resulting in prolonged systemic exposure. In the case of triptolide, a bioactive diterpenoid, acupuncture increased its plasma levels and AUC. Some studies reported changes in biomarkers associated with liver function under elevated compound exposure, though no acute adverse effects were noted for commonly used agents. ST36 acupuncture can alter drug pharmacokinetics, potentially impacting drug exposure and clinical response. Awareness of such interactions is important when combining acupuncture with medication. Further studies are warranted to ensure the safe and effective integration of acupuncture into pharmacological treatment strategies.